RTW INVESTMENTS, LP
Institutional investor · Portfolio as of Q2 2021
Top Holdings113 positions
Rocket Pharmaceuticals Inc | 15M | $663.9M | 10.0% | $18.09 | +139.51% | 10 qtrssince 2019-Q1 | Decreased 0 |
SPDR S&P 500 ETF Trust | 996,255 | $426.5M | 6.4% | $371.30 | +8.23% | 2 qtrssince 2021-Q1 | Increased 64 |
Alnylam Pharmaceuticals Inc | 1.7M | $285.4M | 4.3% | $81.30 | +104.03% | 10 qtrssince 2019-Q1 | Unchanged 0 |
Dicerna Pharmaceuticals Inc | 7.5M | $280.7M | 4.2% | — | — | 10 qtrssince 2019-Q1 | Increased 57 |
Vericel Corp | 4.5M | $237.2M | 3.6% | $17.25 | +234.99% | 10 qtrssince 2019-Q1 | Unchanged 0 |
Mirati Therapeutics Inc | 1.5M | $235.4M | 3.6% | — | — | 10 qtrssince 2019-Q1 | Increased 62 |
Illumina Inc | 482,791 | $228.5M | 3.4% | $334.89 | +39.19% | 4 qtrssince 2020-Q3 | Increased 56 |
PTC Therapeutics Inc | 5.3M | $223.8M | 3.4% | $41.64 | +0.91% | 10 qtrssince 2019-Q1 | Unchanged 0 |
ESTABLISHMENT LABS HLDGS INC | 2.3M | $202.6M | 3.1% | $21.90 | +295.58% | 10 qtrssince 2019-Q1 | Unchanged 0 |
Masimo Corp | 826,210 | $200.3M | 3.0% | $193.01 | +27.91% | 10 qtrssince 2019-Q1 | Increased 74 |
NATERA INC | 1.7M | $194.4M | 2.9% | $38.24 | +196.89% | 8 qtrssince 2019-Q3 | Unchanged 0 |
PROTAGONIST THERAPEUTICS INC | 3.5M | $157.4M | 2.4% | $11.14 | +302.81% | 8 qtrssince 2019-Q3 | Unchanged 0 |
10X Genomics Inc | 734,481 | $143.8M | 2.2% | $89.68 | +124.49% | 8 qtrssince 2019-Q3 | Increased 54 |
CELLDEX THERAPEUTICS INC NEW | 3.9M | $130.7M | 2.0% | $14.15 | +149.90% | 5 qtrssince 2020-Q2 | Unchanged 0 |
DERMTECH INC | 3.1M | $129.6M | 2.0% | — | — | 8 qtrssince 2019-Q3 | Unchanged 0 |
GLOBUS MED INC | 1.7M | $129.5M | 2.0% | $64.85 | +17.75% | 3 qtrssince 2020-Q4 | Unchanged 0 |
AXONICS INC | 1.9M | $123.3M | 1.9% | — | — | 10 qtrssince 2019-Q1 | Increased 49 |
STOKE THERAPEUTICS INC | 3.6M | $122.7M | 1.9% | $29.30 | +12.65% | 9 qtrssince 2019-Q2 | Unchanged 0 |
GUARDANT HEALTH INC | 918,253 | $114M | 1.7% | $119.28 | +4.12% | 4 qtrssince 2020-Q3 | Increased 66 |
Quidel Corp | 878,533 | $112.6M | 1.7% | $126.39 | -89.38% | 2 qtrssince 2021-Q1 | Unchanged 0 |
RTW INVESTMENTS, LP manages $6.6B across 113 positions as of Q2 2021. Top holdings: RCKT (10.0%), SPY (6.4%), ALNY (4.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3.5/5.0.
Active quarter - 15 new positions, 13 exits, 21 increased. Top move: MASI (INCREASED, conviction 74). Portfolio: $6.6B across 113 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR